Summary
- Current Price
- As of today, ORKA price is $32.97, down -0.60% on
- Current Price All-Time High
- ORKA price is currently -100.00% below its historical high of $75,932,640.00 set on
- Market Cap
- ORKA current market cap is $2B, up +323.33% over the past 365 days
- PE Ratio
- ORKA PE ratio is unknown
- Revenue
- ORKA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ORKA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Oruka Therapeutics, Inc. |
| Ticker | NASDAQ: ORKA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | orukatx.com |
| Employees | 28 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.97 | |
| Price, 1D Change | -0.60% | |
| $2B | ||
| - | ||
| - | ||
| 1.05 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.99 | ||
| EPS, 1Y Change | -12.20% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $19.36 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ABIO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.99 | ||
| EPS Estimate | -$2.06 | |
| EPS Est. Change | +58.59% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $32.97 | |
| Price Target | - | $53.00 |
| Price Tgt. Change | - | +60.75% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.06 | N/A | - | |
| -$2.39 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.97 | |
| $22.48 | ||
| SMA 200 vs Price | -31.82% | |
| $32.41 | ||
| SMA 50 vs Price | -1.69% | |
| 1.05 | ||
| $2.02 | ||
| 48.64 | ||
| 63.22% | ||
| 74.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $19.36 | |
| Upcoming | N/A | N/A |
| 58.71% | ||
| Total Dividend | $19.36 | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.99 | ||
| -$27.00K | ||
| - | ||
| -$88.12M | ||
| - | ||
| -$83.72M | ||
| - | ||
| -$88.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 28.89 | ||
| 28.89 | ||
| - | ||
| - | ||
| 69.48 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.30 | ||
| -10.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $379.29M | ||
| $375.65M | ||
| $396.02M | ||
| $376.87M | ||
| $13.80M | ||
| $13.04M | ||
| $968.00K | ||
| $213.00K | ||
| $3.46M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $83.72M | ||
| $88.10M | ||
| $27.00K | ||
| $0.00 | ||
| $27.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$57.84M | ||
| -$330.13M | ||
| $449.54M | ||
| $189.00K | ||
| -$58.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| BTIG | → | |
| UBS | ||
| Piper Sandler | ||
| Jefferies | ||
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | ||
| Barclays | ||
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with ORKA
FAQ
What is the ticker symbol for Oruka Therapeutics, Inc.?
The ticker symbol for Oruka Therapeutics, Inc. is NASDAQ:ORKA
Does Oruka Therapeutics, Inc. pay dividends?
No, Oruka Therapeutics, Inc. does not pay dividends
What sector is Oruka Therapeutics, Inc. in?
Oruka Therapeutics, Inc. is in the Healthcare sector
What industry is Oruka Therapeutics, Inc. in?
Oruka Therapeutics, Inc. is in the Biotechnology industry
What country is Oruka Therapeutics, Inc. based in?
Oruka Therapeutics, Inc. is headquartered in United States
When did Oruka Therapeutics, Inc. go public?
Oruka Therapeutics, Inc. initial public offering (IPO) was on August 8, 1997
Is Oruka Therapeutics, Inc. in the S&P 500?
No, Oruka Therapeutics, Inc. is not included in the S&P 500 index
Is Oruka Therapeutics, Inc. in the NASDAQ 100?
No, Oruka Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Oruka Therapeutics, Inc. in the Dow Jones?
No, Oruka Therapeutics, Inc. is not included in the Dow Jones index
When was Oruka Therapeutics, Inc. last earnings report?
Oruka Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does Oruka Therapeutics, Inc. report earnings?
The next expected earnings date for Oruka Therapeutics, Inc. is March 9, 2026
Data Sources & References
- ORKA Official Website orukatx.com
- ORKA Profile on Yahoo Finance finance.yahoo.com/quote/ORKA
- ORKA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/orka